Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

The 2022 OncoAlert Colloquium Day 2: GU Oncology

Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden
The 2022 OncoAlert Colloquium Day 2: GU Oncology ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )
31 Jan 2023

The 2022 OncoAlert Colloquium Day 1: Breast Cancer

Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden
The 2022 OncoAlert Colloquium Day 1: Breast Cancer ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )
30 Jan 2023

Latest in lung cancer genomic testing

Prof Sanjay Popat - The Royal Marsden, London, UK
Latest in lung cancer genomic testing ( Prof Sanjay Popat - The Royal Marsden, London, UK )
26 Jan 2023

The placebo effect in oncology trials and the criteria for approving drugs

Dr Bishal Gyawali - Queen's University, Kingston, Canada
The placebo effect in oncology trials and the criteria for approving drugs ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
18 Jan 2023

ZUMA-7: Axi-cel is superior to standard of care across common prognostic subgroups in R/R LBCL

Dr Fred Locke - Moffitt Cancer Center, Tampa, USA
ZUMA-7: Axi-cel is superior to standard of care across common prognostic subgroups in R/R LBCL ( Dr Fred Locke - Moffitt Cancer Center, Tampa, USA )
23 Dec 2022

T-DXd demonstrates high levels of efficacy in patients with HER2+ unresectable and/or mBC previously treated with T-DM1

Dr Ian Krop - Yale Cancer Center, Connecticut, USA
T-DXd demonstrates high levels of efficacy in patients with HER2+ unresectable and/or mBC previously treated with T-DM1 ( Dr Ian Krop - Yale Cancer Center, Connecticut, USA )
23 Dec 2022

ASH 2022: Multiple myeloma roundup

Dr Thomas Martin - UCSF Medical Centre, San Francisco, USA
ASH 2022: Multiple myeloma roundup ( Dr Thomas Martin - UCSF Medical Centre, San Francisco, USA )
22 Dec 2022

Gemtuzumab ozogamicin plus chemotherapy improves outcomes in intermediate-risk cytogenetic AML

Dr Eunice Wang - Roswell Park Comprehensive Cancer Center, New York, USA
Gemtuzumab ozogamicin plus chemotherapy improves outcomes in intermediate-risk cytogenetic AML ( Dr Eunice Wang - Roswell Park Comprehensive Cancer Center, New York, USA )
22 Dec 2022

Comment: POLAR gene profile can identify which patients can safely avoid radiation therapy after breast-conserving surgery

Prof Christos Markopoulos- National and Kapodistrian University of Athens, Athens, Greece
Comment: POLAR gene profile can identify which patients can safely avoid radiation therapy after breast-conserving surgery ( Prof Christos Markopoulos- National and Kapodistrian University of Athens, Athens, Greece )
22 Dec 2022

Updates from TAILORx and RxPONDER: Implications for practice

Prof Christos Markopoulos and Dr Kevin Kalinsky
Updates from TAILORx and RxPONDER: Implications for practice ( Prof Christos Markopoulos and Dr Kevin Kalinsky )
21 Dec 2022

Maximising cancer treatment and research through omics, data sharing, and open science

Dr Simon Parker - Data protection co-ordinator at the German Human Genome-phenome Archive
Maximising cancer treatment and research through omics, data sharing, and open science ( Dr Simon Parker - Data protection co-ordinator at the German Human Genome-phenome Archive )
20 Dec 2022

Talquetamab: Robust efficacy and manageable safety for heavily pretreated R/R multiple myeloma

Dr Ajai Chari - Mount Sinai School of Medicine, New York, USA
Talquetamab: Robust efficacy and manageable safety for heavily pretreated R/R multiple myeloma ( Dr Ajai Chari - Mount Sinai School of Medicine, New York, USA )
20 Dec 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation